公开(公告)号：WO1996018722A3

公开(公告)日：1996-06-20

申请号：PCT/MX1995000009

申请日：1995-12-08

Applicant: CENTRO DE INVESTIGACION Y DE ESTUDIOS AVANZADOS DEL I.P.N. ,  HERRERA ESTRELLA, Alfredo, Heriberto ,  FLORES MARTINEZ, Alberto ,  CHET, Ilan

Inventor： CENTRO DE INVESTIGACION Y DE ESTUDIOS AVANZADOS DEL I.P.N.

IPC: C12N01/00

公开(公告)号：WO9618722A2

公开(公告)日：1996-06-20

申请号：PCT/MX9500009

申请日：1995-12-08

Applicant: INVEST Y DE ESTUDIOS AVANZADOS ,  HERRERA ESTRELLA ALFREDO HERIB ,  FLORES MARTINEZ ALBERTO ,  CHET ILAN

Inventor： HERRERA ESTRELLA ALFREDO HERIB ,  FLORES MARTINEZ ALBERTO ,  CHET ILAN

IPC: A01N63/04 ,  C12N1/15 ,  C12N9/58 ,  C12N9/60 ,  C12N15/80 ,  C12N15/81 ,  C12N

CPC classification number: C12R1/885 ,  A01K2217/05 ,  A01N63/04 ,  C12N9/58 ,  C12N9/60 ,  C12N15/80 ,  C12N15/815

Abstract: Improved strains of Trichoderma spp. have been obtained as agents for the biological control of phytopathogenic fungi and nematodes, which strains are capable of overproducing a proteinase, by using a transformation process which involves the introduction of the gene prb1 of Trichoderma which codes for the proteinase PrB1 under the control of the appropriate elements of regulation of the expression, in multiple copies and in a stable way, whereby the control of the disease caused by pathogenic fungi or by netamodes is superior in the transgenic strain than in the wild strain used as receptor of the genetic information.

Abstract translation: 改良木霉菌株 已被获得作为生物防治植物病原真菌和线虫的药剂，该菌株能够过量产生蛋白酶，通过使用涉及引入木霉属基因prb1的转化过程，该基因prb1编码在蛋白酶PrB1的控制下 以多拷贝和稳定的方式调控表达的适当元件，其中由病原真菌或netamodes引起的疾病的控制在转基因株中优于用作遗传信息的受体的野生株。

公开(公告)号：WO2002090492A2

公开(公告)日：2002-11-14

申请号：PCT/IL2002/000351

申请日：2002-05-05

Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM ,  CHET, Ilan ,  VITERBO, Ada

Inventor： CHET, Ilan ,  VITERBO, Ada

IPC: C12N

CPC classification number: C12Y302/01014 ,  C12N9/2442

Abstract: A method of preventing or treating a disease or a condition associated with a chitin-containing organism in an individual, the method comprising administering to the individual a therapeutically effective amount of a pharmaceutical composition including as an active ingredient a polypeptide displaying an endochitinase activity.

Abstract translation: 一种预防或治疗与个体中​​含有几丁质的生物有关的疾病或病症的方法，所述方法包括向个体施用治疗有效量的药物组合物，其包含作为活性成分显示内切素酶活性的多肽。

公开(公告)号：WO2002056683A3

公开(公告)日：2002-07-25

申请号：PCT/US2002/001204

申请日：2002-01-17

Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD. ,  YISSUM RESEARCH AND DEVELOPMENT ,  MCINNIS, Patricia ,  MIRELMAN, David ,  ABRAMSKI, Miriam ,  CHET, Ilan ,  MIRON, Talia ,  RABINKOV, Aharon ,  WILCHEK, Meir

Inventor： MIRELMAN, David ,  ABRAMSKI, Miriam ,  CHET, Ilan ,  MIRON, Talia ,  RABINKOV, Aharon ,  WILCHEK, Meir

IPC: A01N41/02

Abstract: Allicin is administered to soil prior to seeding or planting in order to protect the plants against pathogenic organisms, such as fungi, bacteria, protozoa and soil nematodes.

公开(公告)号：WO02056683A2

公开(公告)日：2002-07-25

申请号：PCT/US0201204

申请日：2002-01-17

Applicant: YEDA RES & DEV ,  YISSUM RES AND DEV ,  MIRELMAN DAVID ,  ABRAMSKI MIRIAM ,  CHET ILAN ,  MIRON TALIA ,  RABINKOV AHARON ,  WILCHEK MEIR ,  MCINNIS PATRICIA

Inventor： MIRELMAN DAVID ,  ABRAMSKI MIRIAM ,  CHET ILAN ,  MIRON TALIA ,  RABINKOV AHARON ,  WILCHEK MEIR

IPC: A01N41/02 ,  A01N65/00 ,  A01N

CPC classification number: A01N41/02 ,  A01N65/42 ,  A01N25/02

Abstract: Allicin is administered to soil prior to seeding or planting in order to protect the plants against pathogenic organisms, such as fungi, bacteria, protozoa and soil nematodes.

Abstract translation: 在接种或种植之前将大蒜素施用于土壤，以保护植物免受致病生物体如真菌，细菌，原生动物和土壤线虫的侵害。

公开(公告)号：WO2002090492A3

公开(公告)日：2002-11-14

申请号：PCT/IL2002/000351

申请日：2002-05-05

Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM ,  CHET, Ilan ,  VITERBO, Ada

Inventor： CHET, Ilan ,  VITERBO, Ada

IPC: C12N15/56

Abstract: A method of preventing or treating a disease or a condition associated with a chitin-containing organism in an individual, the method comprising administering to the individual a therapeutically effective amount of a pharmaceutical composition including as an active ingredient a polypeptide displaying an endochitinase activity.